Gender Differences In Cardiovascular Disease: A Comparative Study Of Clinical Presentation, Management, And Outcomes
: Introduction; - Gender differences in cardiovascular disease (CVD) extend beyond biological variations to encompass sociocultural, behavioral, and healthcare-access factors that influence disease recognition, management, and outcomes. Despite major advances in cardiac therapeutics, sex-specific inequities persist globally, with women often underdiagnosed and undertreated. This study aimed to compare the clinical presentation, management patterns, and short-term outcomes of CVD between men and women in a tertiary-care setting. Methods: A hospital-based comparative cross-sectional study was conducted among 300 adult CVD patients (150 males, 150 females) attending the Department of Cardiology between April 2024 – March 2025. Data on demographics, risk factors, clinical features, investigations, treatment modalities, and 30-day outcomes were collected using a pre-tested proforma. Statistical analyses were performed using SPSS v26.0. Chi-square and t-tests assessed gender differences; multivariate logistic regression identified independent predictors of adverse outcomes. A p-value < 0.05 was considered significant. Results: Females were older (61.6 ± 11.5 y) than males (57.2 ± 10.8 y, p = 0.001) and had higher rates of diabetes (42.7 %) and obesity (34.0 %), whereas males predominated in smoking (76.7 %) and alcohol use (68.7 %) (p < 0.001). Women presented more often with atypical symptoms (38.7 % vs 17.3 %, p < 0.001) and longer pre-hospital delay (5.0 ± 2.4 h vs 3.2 ± 1.6 h, p < 0.001). Coronary angiography and PCI were performed less frequently in females (67.3 % vs 83.3 %, p = 0.002; 36.7 % vs 52.0 %, p = 0.009). In-hospital complications occurred in 27.3 % of women vs 16.7 % of men (p = 0.022), and 30-day readmission was higher in females (14.0 % vs 7.3 %, p = 0.039). Multivariate analysis identified female gender (AOR 1.89; 95 % CI 1.01–3.56; p = 0.046), age > 65 y (AOR 2.41; p = 0.008), diabetes (AOR 1.98; p = 0.034), and presentation delay > 4 h (AOR 2.73; p = 0.004) as independent predictors of adverse outcomes. Conclusion: Significant gender disparities persist in the presentation and management of cardiovascular disease. Women tend to present later with atypical symptoms, receive fewer invasive interventions, and experience higher complication and readmission rates. These findings underscore the need for gender-responsive cardiovascular care, equitable procedural access, and heightened clinical vigilance for atypical presentations in women to improve overall cardiac outcomes.